Abbott Laboratories (ABT) Raw Materials (2016 - 2026)

Abbott Laboratories' Raw Materials history spans 18 years, with the latest figure at $1.7 billion for Q1 2026.

On a quarterly basis, Raw Materials rose 2.08% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 billion, a 2.08% increase, with the full-year FY2025 number at $1.6 billion, down 2.78% from a year prior.
Raw Materials hit $1.7 billion in Q1 2026 for Abbott Laboratories, up from $1.6 billion in the prior quarter.
Over the last five years, Raw Materials for ABT hit a ceiling of $2.0 billion in Q2 2023 and a floor of $1.5 billion in Q1 2022.
Historically, Raw Materials has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2022.
Biggest five-year swings in Raw Materials: grew 26.08% in 2023 and later dropped 10.73% in 2025.
Tracing ABT's Raw Materials over 5 years: stood at $1.7 billion in 2022, then grew by 7.64% to $1.8 billion in 2023, then dropped by 8.97% to $1.7 billion in 2024, then decreased by 2.78% to $1.6 billion in 2025, then rose by 7.03% to $1.7 billion in 2026.
Business Quant data shows Raw Materials for ABT at $1.7 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.

Peer Comparison